GB0130393D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0130393D0
GB0130393D0 GBGB0130393.2A GB0130393A GB0130393D0 GB 0130393 D0 GB0130393 D0 GB 0130393D0 GB 0130393 A GB0130393 A GB 0130393A GB 0130393 D0 GB0130393 D0 GB 0130393D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0130393.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB0130393.2A priority Critical patent/GB0130393D0/en
Publication of GB0130393D0 publication Critical patent/GB0130393D0/en
Priority to PCT/GB2002/005676 priority patent/WO2003051873A1/en
Priority to AU2002352389A priority patent/AU2002352389A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0130393.2A 2001-12-19 2001-12-19 Compounds Ceased GB0130393D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0130393.2A GB0130393D0 (en) 2001-12-19 2001-12-19 Compounds
PCT/GB2002/005676 WO2003051873A1 (en) 2001-12-19 2002-12-13 Piperazine compounds and their phamaceutical use
AU2002352389A AU2002352389A1 (en) 2001-12-19 2002-12-13 Piperazine compounds and their phamaceutical use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0130393.2A GB0130393D0 (en) 2001-12-19 2001-12-19 Compounds

Publications (1)

Publication Number Publication Date
GB0130393D0 true GB0130393D0 (en) 2002-02-06

Family

ID=9927958

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0130393.2A Ceased GB0130393D0 (en) 2001-12-19 2001-12-19 Compounds

Country Status (3)

Country Link
AU (1) AU2002352389A1 (en)
GB (1) GB0130393D0 (en)
WO (1) WO2003051873A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060040937A1 (en) * 2002-09-18 2006-02-23 Glaxo Group Limited N-aroyl cyclic amines as orexin receptor antagonists
DE60335891D1 (en) 2002-10-11 2011-03-10 Actelion Pharmaceuticals Ltd SULPHONYLAMINE ACID DERIVATIVES AND THEIR USE AS OREXIN RECEPTOR ANTAGONIST
CA2515119A1 (en) 2003-02-07 2004-08-19 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivative
DE602004011204T2 (en) 2003-04-28 2008-12-24 Actelion Pharmaceuticals Ltd. QUINOXALIN-3-ON CONDITIONS AS OREXIN RECEPTOR ANTAGONISTS.
CN1926109B (en) 2004-03-01 2011-04-13 埃科特莱茵药品有限公司 Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
US7501395B2 (en) 2005-04-25 2009-03-10 Eisai R & D Management Co., Ltd. Method of screening for antianxiety drugs
WO2007126935A2 (en) 2006-03-29 2007-11-08 Merck & Co., Inc. Diazepan orexin receptor antagonists
AU2007272854B2 (en) 2006-07-14 2013-08-01 Merck Sharp & Dohme Corp. Bridged diazepan orexin receptor antagonists
US20100016401A1 (en) * 2006-09-29 2010-01-21 Actelion Phamaceuticals Ltd. 3-aza-bicyclo[3.1.0]hexane derivatives
PE20081229A1 (en) 2006-12-01 2008-08-28 Merck & Co Inc DIAZEPAM OREXIN RECEPTOR ANTAGONISTS REPLACED
ES2357992T3 (en) 2006-12-01 2011-05-04 Actelion Pharmaceuticals Ltd. DERIVATIVES OF 3-HETEROARIL (AMINO OR AMIDO) -1- (BIFENIL OR PHENYLTIAZOLIL) CARBONYLPIPERIDINE AS INHIBITORS OF THE OREXINE RECEIVER.
AR064561A1 (en) * 2006-12-28 2009-04-08 Actelion Pharmaceuticals Ltd DERIVATIVES OF 2-AZA-BICYCLE [3.1.0] HEXANE AND ITS USE IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DISEASES RELATED TO GENERAL DYSFUNCTIONS OF THE OREXINE SYSTEM.
CL2008000836A1 (en) 2007-03-26 2008-11-07 Actelion Pharmaceuticals Ltd Thiazolidine derivative compounds, orexin receptor antagonists; pharmaceutical composition that includes them; and its use in the treatment of emotional neurosis, severe depression, psychotic disorders, Alzheimer's, parkinson's, pain, among others.
WO2008143856A1 (en) 2007-05-18 2008-11-27 Merck & Co., Inc. Oxo bridged diazepan orexin receptor antagonists
ATE540944T1 (en) 2007-05-23 2012-01-15 Merck Sharp & Dohme PYRIDYLPIPERIDINOREXINE RECEPTOR ANTAGONISTS
WO2008150364A1 (en) 2007-05-23 2008-12-11 Merck & Co., Inc. Cyclopropyl pyrrolidine orexin receptor antagonists
CN101874028B (en) 2007-07-27 2012-11-14 埃科特莱茵药品有限公司 2-aza-bicyclo[3.3.0]octane derivatives
EP2207778A2 (en) 2007-09-24 2010-07-21 Actelion Pharmaceuticals Ltd. Pyrrolidines and piperidines as orexin receptor antagonists
NZ588080A (en) 2008-02-21 2012-04-27 Actelion Pharmaceuticals Ltd 2-Aza-bicyclo[2.2.1]heptane derivatives
EP2275421A1 (en) 2009-07-15 2011-01-19 Rottapharm S.p.A. Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
AR088352A1 (en) 2011-10-19 2014-05-28 Merck Sharp & Dohme ANTAGONISTS OF THE RECEIVER OF 2-PIRIDILOXI-4-NITRILE OREXINE
CA2863413A1 (en) 2012-02-07 2013-08-15 Eolas Therapeutics, Inc. Substituted prolines / piperidines as orexin receptor antagonists
US9440982B2 (en) 2012-02-07 2016-09-13 Eolas Therapeutics, Inc. Substituted prolines/piperidines as orexin receptor antagonists
CN104334544B (en) 2012-06-04 2016-10-19 埃科特莱茵药品有限公司 Benzimidazole proline derivative
MX2015004638A (en) 2012-10-10 2015-07-14 Actelion Pharmaceuticals Ltd Orexin receptor antagonists which are [ortho bi (hetero )aryl]-[2-(meta bi (hetero )aryl)-pyrrolidin-1-yl]-methanone derivatives.
CN105051040A (en) 2013-03-12 2015-11-11 埃科特莱茵药品有限公司 Azetidine amide derivatives as orexin receptor antagonists
UA119151C2 (en) 2013-12-03 2019-05-10 Ідорсія Фармасьютікалз Лтд Crystalline salt form of (s)-(2-(6-chloro-7-methyl-1 h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1 -yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
SI3077389T1 (en) 2013-12-03 2018-01-31 Idorsia Pharmaceuticals Ltd Crystalline form of (s)-(2-(6-chloro-7-methyl-1h-benzo(d)imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists
CA2930053A1 (en) 2013-12-04 2015-06-11 Actelion Pharmaceuticals Ltd Use of benzimidazole-proline derivatives
EP3180332B1 (en) 2014-08-13 2021-10-27 Eolas Therapeutics Inc. Difluoropyrrolidines as orexin receptor modulators
EA036542B9 (en) 2016-02-12 2020-12-22 Астразенека Аб Halo-substituted piperidines as orexin receptor modulators
US20190151304A1 (en) 2016-05-10 2019-05-23 Inserm (Institut National De La Santé Et De La Rechercjae Médicale Methods and pharmaceutical compositions for the treatment of autoimmune inflammatory
WO2020007964A1 (en) 2018-07-05 2020-01-09 Idorsia Pharmaceuticals Ltd 2-(2-azabicyclo[3.1.0]hexan-1-yl)-1h-benzimidazole derivatives
WO2020099511A1 (en) 2018-11-14 2020-05-22 Idorsia Pharmaceuticals Ltd Benzimidazole-2-methyl-morpholine derivatives
CA3140170A1 (en) 2019-06-04 2020-12-10 Belew Mekonnen Imidazolo derivatives, compositions and methods as orexin antagonists
AR129309A1 (en) 2022-05-13 2024-08-07 Idorsia Pharmaceuticals Ltd DERIVATIVES OF HYDRAZINE-N-CARBOXAMIDE CYCLIC SUBSTITUTED WITH THIAZOLOARYL-METHYL

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK247789A (en) * 1988-05-23 1989-11-24 Glaxo Group Ltd piperazine

Also Published As

Publication number Publication date
WO2003051873A1 (en) 2003-06-26
AU2002352389A1 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
AU2002349297A8 (en) Statin-like compounds
GB0124463D0 (en) Compounds
GB0101996D0 (en) Organtic compounds
GB0102668D0 (en) Compounds
GB0112324D0 (en) Compounds
GB0130393D0 (en) Compounds
GB0102665D0 (en) Compounds
GB0121488D0 (en) Compounds
GB0108102D0 (en) Compounds
GB0102673D0 (en) Compounds
GB0119474D0 (en) Compounds
GB0119472D0 (en) Compounds
GB0118364D0 (en) Compounds
GB0115178D0 (en) Compounds
GB0119473D0 (en) Compounds
GB0120344D0 (en) Compounds
GB0105098D0 (en) Compounds
GB0120342D0 (en) Compounds
GB0125121D0 (en) Compounds
GB0103314D0 (en) Compounds
GB0120321D0 (en) Compounds
GB0115863D0 (en) Compounds
GB0120324D0 (en) Compounds
GB0104398D0 (en) Compounds
GB0102670D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)